Related Experiment Video
Updated: Jun 6, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Delivery Outcomes in the First 3 Years Following the Clinical Introduction of the Dinoprostone Vaginal Insert in
Keisuke Nakajima1, Takeshi Nagamatsu1,2, Hiroaki Tanaka3
1Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Objective:
To evaluate utilization patterns, safety, and delivery outcomes associated with the recently introduced dinoprostone vaginal insert in Japan using multicenter real-world data.
Methods:
This two-stage nationwide survey targeted training institutions certified by the Japan Society of Obstetrics and Gynecology. An online questionnaire was sent to 690 institutions to identify facilities eligible for secondary data collection. Participating institutions submitted clinical information for up to 25 consecutive cases in which labor was induced with the insert between January and December 2021. Patient characteristics, insert use, delivery outcomes, and adverse events were summarized. In nulliparas, two subgroup comparisons were conducted: (1) those achieving cervical ripening with the insert alone (P) versus those requiring subsequent mechanical ripening (P to M), and (2) those receiving mechanical ripening before the insert (M to P) versus those receiving the insert first (P to M).
Results:
Of 973 registered cases from 69 institutions, 947 were eligible for analysis. Nulliparous women accounted for 74.8%. The cesarean section rate was 30.7% overall (36.3% in nulliparas; 14.2% in multiparas). Median time from insert initiation to delivery was 31.6 h. Uterine tachysystole occurred in 18.1% and fetal heart rate abnormalities in 15.8%, but timely management prevented serious outcomes. In subgroup analyses, nulliparas ripened with the insert alone demonstrated shorter induction-to-delivery intervals, lower cesarean and oxytocin-use rates, but more tachysystole. Among cases requiring both methods, the order of ripening techniques did not affect vaginal delivery success.
Conclusion:
This first multicenter real-world evaluation demonstrates that the insert is effective and generally safe for cervical ripening and labor induction in Japan.
Related Concept Videos
Intrauterine Drug Delivery Systems
Oral Drug Delivery Systems: Continuous-Release Systems
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Oral Drug Delivery Systems: Delayed-Release Systems
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

